Choate Investment Advisors Eli Lilly & CO Transaction History

Choate Investment Advisors

$3.79 Billion
Q2 2024

A detailed history of Choate Investment Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Choate Investment Advisors holds 18,256 shares of LLY stock, worth $16 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

18,256

Previous 19,618 6.94%

Holding current value

$16 Million

Previous $15.3 Million 8.3%

% of portfolio

0.44%

Previous 0.41%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $987,272 - $1.24 Million	-1,362 Reduced 6.94%	18,256 $16.5 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $8,290 - $11,091	14 Added 0.07%	19,618 $15.3 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $758,899 - $894,642	1,445 Added 7.96%	19,604 $11.4 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $698,562 - $963,075	1,607 Added 9.71%	18,159 $9.75 Million
Q2 2023 Aug 01, 2023	BUY	$350.74 - $468.98 $70,849 - $94,733	202 Added 1.24%	16,552 $7.76 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $154,072 - $180,950	-496 Reduced 2.94%	16,350 $5.61 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $613,195 - $714,495	1,907 Added 12.77%	16,846 $6.16 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $100,210 - $114,200	-338 Reduced 2.21%	14,939 $4.83 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $1.75 Million - $2.06 Million	-6,290 Reduced 29.16%	15,277 $4.95 Million
Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $1.59 Million - $1.98 Million	6,788 Added 45.93%	21,567 $6.18 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $17,988 - $22,323	-80 Reduced 0.54%	14,779 $4.08 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $390,016 - $479,969	-1,760 Reduced 10.59%	14,859 $3.43 Million
Q2 2021 Jul 30, 2021	SELL	$180.55 - $233.54 $154,009 - $199,209	-853 Reduced 4.88%	16,619 $3.81 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $71,972 - $93,171	438 Added 2.57%	17,472 $3.26 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $2,739 - $3,625	21 Added 0.12%	17,034 $2.88 Million
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $63,751 - $73,740	-436 Reduced 2.5%	17,013 $2.52 Million
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $173,253 - $208,508	-1,270 Reduced 6.78%	17,449 $2.87 Million
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $17,857 - $22,102	-150 Reduced 0.79%	18,719 $2.6 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $26,697 - $29,040	-250 Reduced 1.31%	18,869 $2.11 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $9,749 - $11,380	-88 Reduced 0.46%	19,119 $2.12 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $182,882 - $215,265	-1,643 Reduced 7.88%	19,207 $2.49 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $256,489 - $287,346	-2,422 Reduced 10.41%	20,850 $2.41 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $120,204 - $150,234	1,400 Added 6.4%	23,272 $2.5 Million
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $57,002 - $65,420	-753 Reduced 3.33%	21,872 $1.87 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $25,528 - $30,134	-344 Reduced 1.5%	22,625 $0
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $5,899 - $6,328	-72 Reduced 0.31%	22,969 $0
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $1.78 Million - $1.97 Million	23,041	23,041 $0

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Account

Choate Investment Advisors Eli Lilly & CO Transaction History